Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

NCT01031069 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

873

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Papillomavirus
Papillomavirus Vaccines

Interventions

BIOLOGICAL: GSK Biologicals' HPV vaccine 580299
BIOLOGICAL: Merck's Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine (Gardasil)

Sponsor

GlaxoSmithKline